Lung Diseases  >>  iniparib (BSI 201)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iniparib (BSI 201) / Sanofi
NCT01086254 / 2009-017270-21: SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

Completed
2
119
Europe
Iniparib, SAR240550, BSI-201, gemcitabine, cisplatin
Sanofi
Non-small Cell Lung Cancer Stage IV
12/11
12/11

Download Options